1. 2022-RA-905-ESGO Mismatch repair deficiency is not applicable as biomarker in cervical cancer, yet MSH-2 has strong prognostic value. (20th October 2022) Authors: van den Berg, Madeleine Charlotte; Berg, Hege Fredriksen; Stokowy, Thomas; Hoivik, Erling; Woie, Kathrine; Engerud, Hilde; Ojesina, Akinyemi I; Salvesen Haldorsen, Ingfrid Helene; Bertelsen, Bjørn Inge; Trovik, Jone; Halle, Mari Kyllesø; Krakstad, Camilla Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A32 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗